Goldman Sachs Group Inc. trimmed its holdings in Masimo Corporation (NASDAQ:MASI) by 23.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 361,361 shares of the medical equipment provider’s stock after selling 111,677 shares during the quarter. Goldman Sachs Group Inc. owned 0.70% of Masimo Corporation worth $32,949,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Fortaleza Asset Management Inc. purchased a new stake in Masimo Corporation during the second quarter valued at about $106,000. Dubuque Bank & Trust Co. increased its holdings in shares of Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after purchasing an additional 61 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Masimo Corporation by 13.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock valued at $184,000 after purchasing an additional 236 shares during the period. Neuberger Berman Group LLC acquired a new position in shares of Masimo Corporation in the 1st quarter valued at about $206,000. Finally, Campbell & CO Investment Adviser LLC acquired a new position in shares of Masimo Corporation in the 2nd quarter valued at about $203,000. 83.21% of the stock is owned by institutional investors.
A number of equities analysts have recently weighed in on MASI shares. Zacks Investment Research downgraded Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BidaskClub downgraded Masimo Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, July 5th. Stifel Nicolaus initiated coverage on Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 target price on the stock. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. Masimo Corporation currently has an average rating of “Hold” and an average target price of $97.00.
Shares of Masimo Corporation (MASI) opened at 85.08 on Wednesday. The firm’s 50-day moving average price is $85.30 and its 200-day moving average price is $90.05. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The company has a market cap of $4.42 billion, a PE ratio of 13.95 and a beta of 0.82.
Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.12. The firm had revenue of $192.90 million for the quarter, compared to analyst estimates of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.57 EPS. Equities analysts predict that Masimo Corporation will post $2.80 EPS for the current fiscal year.
In other Masimo Corporation news, insider Rick Fishel sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $94.85, for a total transaction of $1,422,750.00. Following the transaction, the insider now owns 35,022 shares of the company’s stock, valued at approximately $3,321,836.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the transaction, the director now directly owns 72,249 shares in the company, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. Insiders have sold a total of 57,000 shares of company stock worth $5,371,340 in the last ninety days. Insiders own 16.60% of the company’s stock.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.